Presumed antiphospholipid syndrome and thrombotic thrombocytopenic purpura: An infrequent association

2Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Antiphospholipid syndrome (APS) is an autoimmune disease that demonstrates antiphospholipid antibodies that cause hypercoagulability and leads to venous and arterial thrombosis. Autoantibodies to a disintegrin-like and metalloprotease with thrombospondin type I motif, member 13 (ADAMTS 13) play a role in the microthrombosis of thrombotic thrombocytopenic purpura in APS patients.

Cite

CITATION STYLE

APA

Dolin, H. H., Dziuba, M., Pappada, S. M., & Papadimos, T. J. (2019). Presumed antiphospholipid syndrome and thrombotic thrombocytopenic purpura: An infrequent association. Clinical Case Reports, 7(10), 1984–1988. https://doi.org/10.1002/ccr3.2416

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free